IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,241,000 | -13.6% | 674,674 | -0.9% | 0.01% | -9.1% |
Q4 2017 | $1,436,000 | +1.3% | 680,753 | +7.1% | 0.01% | 0.0% |
Q3 2017 | $1,418,000 | +32.0% | 635,853 | +1.8% | 0.01% | +22.2% |
Q2 2017 | $1,074,000 | -50.5% | 624,497 | -28.9% | 0.01% | -50.0% |
Q1 2017 | $2,170,000 | +32.6% | 878,417 | -19.5% | 0.02% | +28.6% |
Q4 2016 | $1,637,000 | -27.4% | 1,091,104 | +23.9% | 0.01% | -33.3% |
Q3 2016 | $2,255,000 | +74.3% | 880,826 | +4.1% | 0.02% | +75.0% |
Q2 2016 | $1,294,000 | -21.1% | 845,780 | +2.1% | 0.01% | -20.0% |
Q1 2016 | $1,641,000 | -20.3% | 828,620 | +24.4% | 0.02% | -31.8% |
Q4 2015 | $2,058,000 | -45.4% | 665,936 | -40.8% | 0.02% | -50.0% |
Q3 2015 | $3,767,000 | -50.3% | 1,124,538 | -45.0% | 0.04% | 0.0% |
Q2 2015 | $7,580,000 | +103.3% | 2,043,214 | +103.3% | 0.04% | -15.4% |
Q1 2015 | $3,729,000 | – | 1,005,067 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |